1.
Case Rep Gastroenterol
; 14(2): 315-319, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32595436
RESUMO
Enoxaparin, a form of low-molecular-weight heparin, can cause a rare, underreported, and often reversible form of hepatocellular injury. This report describes a case of enoxaparin-induced hepatotoxicity in a 61-year-old male diagnosed with pulmonary embolism. Elevations of liver enzymes were noted within 1 week of starting the drug, followed by a dramatic improvement upon its discontinuation, with subsequent normalization in the following days.